Sana Biotechnology, Inc. (SANA): A Bull Case Theory
We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...
Hosted on MSN22d
Sana stock rallies 280% on pancreatic cell transplant study
The pancreatic cell therapy is engineered with Sana’s (NASDAQ:SANA) hypoimmune, or HIP, technology. Sana (SANA) said results showed the survival and function of pancreatic beta cells at four ...
Sana Biotechnology’s Promising UP421 Results and Potential Upside: A Buy Rating Affirmed
Analyst Vikram Purohit from Morgan Stanley maintained a Buy rating on Sana Biotechnology (SANA – Research Report) and keeping the price target ...
MarketWatch22d
Sana Biotechnology Shares Spike Following Successful Transplantation
Shares of Sana Biotechnology surged after the company ... an allogeneic primary islet cell therapy engineered with its hypoimmune technology, into a patient with type 1 diabetes without the ...
Taiwan News22d
Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without Immunosuppression Results ...